Filter Results :

Your search for Diabetes returned 179 reports

Sort by


Patient Registry Software Market by Database Type (Drug, Device, Diabetes, Cancer, Asthma, CKD), Software (Integrated, Standalone), Delivery (On-Premise, Cloud), Functionality (PHM, HIE, POC) & End User (Government, Hospital, Pharma) - Forecasts to 2021

25 Jul 2016  |  Published by:  MarketsandMarkets
The patient registry software market is poised to reach USD 1,314.3 million by 2021 from USD 734.7 million in 2016 at a CAGR of 12.3% from 2016 to 2021. This market is categorized on the basis of product type, pricing model, deployment model, type of database, functionality, end user, and regi...

$ 5,650.00

Read More

Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021

18 Jul 2016  |  Published by:  MarketsandMarkets
The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute the maximum share to the overall market in 2016. Advancements in cord blood preservation...

$ 5,650.00

Read More

Digital Therapeutics Market by Application (Prevention (Prediabetes, Obesity), Care (Diabetes, CVD, CNS, CRD, Smoking Cessation, Musculoskeletal)), Sales Channel (B2C (Patient, Caregiver), B2B (Provider, Payer, Employer, Pharma)) - Global Forecast to 2021

01 Jul 2016  |  Published by:  MarketsandMarkets
The digital therapeutics market in terms of value is expected to reach USD 457.9 million by 2021 from USD 110 million in 2016, growing at a CAGR of 27.7% from 2016 to 2021. This market is categorized on the basis of application, sales channel, and region. Major factors contributing to the grow...

$ 5,650.00

Read More

Global Diabetes Partnering 2010 to 2016

01 Jul 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry secto...

$ 1,995.00

Read More

Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

08 Jun 2016  |  Published by:  Global Markets Direct
Summary‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Type 1 Diabetes (Juvenile Diabetes), complete with anal...

$ 2,000.00

Read More

EpiCast Report: Type 2 Diabetes - Epidemiology Forecast to 2025

06 Jun 2016  |  Published by:  GlobalData
SummaryType 2 diabetes (T2D), formerly known as non-insulin dependent diabetes mellitus or adult-onset diabetes mellitus, is a chronic disorder of glucose equilibrium that results from the body’s inability to make use of available insulin along with relative insulin deficiency. T2D constitutes appro...

$ 3,995.00

Read More

Diabetes Insipidus Global Clinical Trials Review, H1, 2016

31 May 2016  |  Published by:  GlobalData
Summary“Diabetes Insipidus Global Clinical Trials Review, H1, 2016" provides an overview of Diabetes Insipidus clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetes Insipidus. Report includes an overview of trial numbers and their average enrollment...

$ 2,500.00

Read More

Type 2 Diabetes - Pipeline Review, H1 2016

27 Apr 2016  |  Published by:  Global Markets Direct
Summary'Type 2 Diabetes - Pipeline Review, H1 2016', provides an overview of the Type 2 Diabetes pipeline landscape. The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes, complete with analysis by stage of development, drug target, mechanism of acti...

$ 2,500.00

Read More

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016

20 Apr 2016  |  Published by:  GlobalData
Summary“Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H1, 2016" provides an overview of Pre-Diabetes/Impaired Glucose Tolerance clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. Report inc...

$ 2,500.00

Read More

Juvenile Diabetes Research Foundation - Medical Equipment - Deals and Alliances Profile

12 Apr 2016  |  Published by:  GlobalData
SummaryJuvenile Diabetes Research Foundation (JDRF) is a research organization that offers biotechnology service provider. The organization provides research and development service for type 1 diabetes. Its services include cure, treat and prevent. JDRF offers human clinical trials researching new d...

$ 250.00

Read More

Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile

07 Apr 2016  |  Published by:  GlobalData
SummaryAbbott Diabetes Care, Inc. (ADC), formerly TheraSense, Inc. a subsidiary of Abbott Laboratories, is a medical device company that discovers, develops, manufactures, and markets pharmaceuticals and medical products for personal use and hospital use. The company's products include glucose monit...

$ 250.00

Read More

Type 2 Diabetes Mellitus: Update Bulletin

01 Apr 2016  |  Published by:  FirstWord
Gain new KOL insights on the latest events that have the potential to impact the treatment landscape of Type 2 Diabetes Mellitus (T2DM). Topics covered include expert opinions on the positive data reported by Novo Nordisk for its novel GLP-1 analogue, semaglutide, from the Phase III SUSTAIN-1 ...

$ 995.00

Read More

Global Type 2 Diabetes Market 2016-2020

23 Mar 2016  |  Published by:  Technavio-Infiniti Research
About Type 2 Diabetes Diabetes, often referred to as diabetes mellitus, is a metabolic disease in which the patients' blood glucose levels remains high. Depending on the cause of development of diabetes, it can be divided into three types: • Type 1 diabetes (or insulin-dependent diabetes mel...

$ 2,500.00

Read More

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

23 Mar 2016  |  Published by:  IMARC
“Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics” provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatme...

$ 1,200.00

Read More

Global Type 1 Diabetes Market 2016-2020

21 Mar 2016  |  Published by:  Technavio-Infiniti Research
About Type 1 Diabetes Drugs Diabetes, often referred to as diabetes mellitus, results in high blood glucose levels. Depending on the cause of development, it can be divided into three types: • Type 1 diabetes (or insulin-dependent diabetes mellitus): The pancreas do not produce the require...

$ 2,500.00

Read More
Total 179 records.